{"id":"W3005879958","doi":"10.1158/1538-7445.sabcs19-p1-19-06","title":"Abstract P1-19-06: Patient-reported outcomes, including work productivity, from the MONALEESA-7 trial of ribociclib plus endocrine therapy in patients with HR+/HER2− advanced breast cancer","year":2020,"lang":"en","type":"article","venue":"Cancer Research","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Hazard ratio; Letrozole; Tamoxifen; Anastrozole; Internal medicine; Breast cancer; Oncology; Population; Quality of life (healthcare); Cancer; Palbociclib; Metastatic breast cancer; Gynecology; Confidence interval; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004782009,0.0004308414,0.0009650453,0.0001804366,0.0002063237,0.00003800214,0.0004938478,0.0001047987,0.0006059307],"category_scores_gemma":[0.0003896638,0.0002781224,0.0001455499,0.001767631,0.0005289486,0.0003513583,0.0002675568,0.001277078,0.00000634011],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001116854,"about_ca_system_score_gemma":0.001331255,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005231715,"about_ca_topic_score_gemma":0.0006284327,"domain_scores_codex":[0.9949075,0.0002655056,0.0008203518,0.0009852138,0.002112818,0.0009086182],"domain_scores_gemma":[0.9969375,0.0005460143,0.0004571645,0.0008751774,0.0008287576,0.0003553855],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1624046,0.0006553807,0.6867802,0.00008601873,0.000539878,0.0000497888,0.002383306,0.0007240782,0.003018588,0.00000487939,0.0003556877,0.1429976],"study_design_scores_gemma":[0.08410944,0.001023874,0.905658,0.000601261,0.00004267219,0.000002565939,0.0004953531,0.000007825285,0.003552541,0.00008257323,0.00410143,0.0003224664],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.977972,0.002422907,0.0000108947,0.0147257,0.0002471333,0.004113227,0.0003684917,0.00007359104,0.00006606755],"genre_scores_gemma":[0.9965048,0.0004990333,0.0001631561,0.0006259526,0.0006112336,0.001305796,0.00008193659,0.0001200331,0.00008805564],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2188778,"threshold_uncertainty_score":0.9999671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09963595940985603,"score_gpt":0.3993271814967906,"score_spread":0.2996912220869346,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}